|Bid||48.70 x 800|
|Ask||48.71 x 1100|
|Day's Range||48.67 - 49.33|
|52 Week Range||26.10 - 49.33|
|Beta (3Y Monthly)||1.44|
|PE Ratio (TTM)||41.63|
|Earnings Date||Jul 31, 2019 - Aug 5, 2019|
|Forward Dividend & Yield||0.16 (0.33%)|
|1y Target Est||43.67|
Bruker (BRKR) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Methode Electronics' (MEI) fourth-quarter fiscal 2019 results suffer from weak automotive sales stemming from lower demand for passenger cars.
THE HAGUE, Netherlands , June 24, 2019 /PRNewswire/ -- At Metabolomics 2019 ( metabolomics2019.org ), Bruker highlights innovative mass spectrometry (MS) and Nuclear Magnetic Resonance (NMR) systems and ...
IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
The acquisition of SuperSonic Imagine is in sync with Hologic's (HOLX) strategy to provide wide-ranging screening, interventional and surgical solutions.
- Introduction of new MALDI Biotyper sirius™ system with additional negative-ion mode to support MALDI research and RUO validation studies, e.g. for colistin-resistance testing - US introduction of Micronaut™ ...
Is Bruker Corporation (NASDAQ:BRKR) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably, but their consensus stock picks historically […]
Introduction of multiple products within the Spinal Hardware, balanced revenue growth across key operating segments and robust international sales perk up NuVasive's (NUVA) share price.
This impending divestment remains integral to Haemonetics' (HAE) asset optimization strategy that aims at improving its operational performance and focusing on core competencies.
Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
The termination of discussion related to Straumann's iTero distribution is a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
LabCorp's (LH) Diagnostics business sees an organic uptick in terms of both revenues and volumes in spite of further price reductions.
The termination of the Straumann agreement comes as a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
Computer Programs and Systems' (CPSI ) move indicates its efforts to strengthen foothold in the healthcare information technology (HCIT) space.
BILLERICA, Mass. , June 14, 2019 PRNewswire/ -- Bruker Corporation (Nasdaq: BRKR) will host an Investor Day on June 20 th , 2019, starting at 8:00 AM Eastern Time , at the Nasdaq MarketSite, 4 Times Square ...